Palo Capital’s ResMed RMD Stock Holding History

Palo Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,090	Closed	-$810K	–	180
2015 Q4	$810K	Sell	15,090 -95	-0.6%	-$5.36K	0.73%	67
2015 Q3	$774K	Buy	15,185 +975	+7%	+$52.5K	0.67%	68
2015 Q2	$932K	Buy	+14,210	New	+$897K	0.73%	68

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Palo Capital's RMD Position: Q1 2016 in Review

Palo Capital sold out of ResMed (RMD) in Q1 2016, closing a stake of 15,090 shares — an estimated $810K sold.

Palo Capital first reported a position in RMD in Q2 2015 and held it in 3 quarters. The position peaked at $932K in Q2 2015. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

Palo Capital reported no remaining ResMed position as of Q1 2016 after selling out during the quarter.
Palo Capital sold 15,090 ResMed shares in Q1 2016, an estimated $810K.
Palo Capital first reported a position in ResMed in Q2 2015 and held it in 3 quarters.
Palo Capital's ResMed position peaked at $932K in Q2 2015.
374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on Palo Capital's 13F filing for Q1 2016, filed 18 Apr 2016.